The ABCB8 Knockout SK-HEP-1 Polyclonal Cells comprise a pool of polyclonal knockout cells originating from the SK-HEP-1 human liver adenocarcinoma cell line, generated via CRISPR/Cas9-mediated gene disruption targeting the ABCB8 locus. This product delivers a heterogeneous population of edited cells with loss-of-function mutations in ABCB8, providing a versatile model system for studying mitochondrial iron homeostasis and associated pathologies without the need for clonal isolation.
SK-HEP-1 is a well-characterized epithelial cell line derived from human liver adenocarcinoma, widely employed as an in vitro model for hepatocellular carcinoma (HCC). It retains key features of liver cancer cells, including aberrant proliferation, metastatic potential, and multidrug resistance phenotypes, making it a suitable background for dissecting genetic determinants of HCC progression and therapeutic evasion.
ABCB8 belongs to the ATP-binding cassette (ABC) transporter superfamily and functions primarily at the inner mitochondrial membrane, facilitating the export of iron from the mitochondrial matrix. This activity is critical for maintaining mitochondrial iron balance, supporting heme biosynthesis, and mitigating oxidative damage. ABCB8 is regulated by upstream signals including NRF2 and HIF1A, and it physically interacts with mitoferrin-1 (SLC25A37), ABCB7, and frataxin to coordinate iron trafficking. Disruption of ABCB8 expression impairs export of mitochondrial iron, resulting in iron overload within the organelle, heightened reactive oxygen species (ROS) production, and enhanced sensitivity to ferroptosis. Downstream effects include altered heme synthesis and engagement of the NRF2/HMOX1 oxidative stress pathway and the GPX4-regulated ferroptosis defense axis.
In the context of SK-HEP-1 hepatocellular carcinoma cells, loss of ABCB8 function exerts pleiotropic consequences that mirror pathological iron dysregulation in liver cancer. Mitochondrial iron retention induced by ABCB8 knockout not only amplifies oxidative stress but also may modulate cell proliferation and drug resistance??hallmarks of aggressive HCC. The interplay between disrupted iron metabolism and ferroptotic cell death offers a unique window into tumor suppression mechanisms and chemotherapeutic vulnerabilities specific to liver malignancies.
This polyclonal knockout cell population is ideally suited for a broad range of mechanistic and translational investigations. Researchers can employ these cells in western blotting to verify ABCB8 protein knockdown, RT-qPCR to assess transcriptional alterations in iron-regulatory genes, and immunofluorescence to examine mitochondrial morphology and marker expression. Iron accumulation can be visualized using FerroOrange staining, while ROS levels are quantifiable with probes such as H2DCFDA. Functional studies encompass apoptosis detection, cell viability assays (MTT/XTT), and ferroptosis induction/rescue protocols to evaluate oxidative death sensitivity. Core application areas include cancer drug resistance, mitochondrial iron metabolism, ferroptosis biology, hepatocellular carcinoma modeling, and oxidative stress research. For further technical information, please contact Ascent Research.
